Name | Sales (Cr) | Profit (Cr) | EBITDA (Cr) | Financial Year |
---|---|---|---|---|
ICRA | 446.11 | 152.24 | 223.73 | MAR, 2024 |
CARE Ratings | 331.68 | 102.56 | 158.82 | MAR, 2024 |
CRISIL | 3,139.52 | 658.44 | 975.14 | DEC, 2023 |
Company | Market Cap (Cr) | Chg (%) | PE (x) | PB (x) | EV to Sales (x) | EV to EBITDA (x) | Dividend Yield (%) |
---|---|---|---|---|---|---|---|
CRISIL | 42,150.55 | -0.90 | 62.96 | 18.72 | 13.30 | 46.62 | 0.94 |
ICRA | 6,136.64 | -0.88 | 40.57 | 6.44 | 13.46 | 41.17 | 1.57 |
CARE Ratings | 4,023.02 | -2.13 | 35.18 | 5.34 | 12.03 | 35.89 | 1.34 |